AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language; H.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Health Issues HCR
S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language; H.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.